A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1

Published:2021-09-30 Issue:1 Volume:20 Page:127-138
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Wirawan Aditya,Tajima Ken,Takahashi Fumiyuki,Mitsuishi Yoichiro,Winardi Wira,Hidayat Moulid^ORCID,Hayakawa Daisuke,Matsumoto Naohisa^ORCID,Izumi Kenta,Asao Tetsuhiko^ORCID,Ko Ryo,Shimada Naoko,Takamochi Kazuya,Suzuki Kenji,Abe Masaaki,Hino Okio,Sekido Yoshitaka^ORCID,Takahashi Kazuhisa

Funder

JSPS KAKENHI

Institute for Environmental & Gender-specific Medicine, Juntendo University

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging roles of histone demethylases in cancers;Cancer and Metastasis Reviews;2024-01-16

2. Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement;Expert Opinion on Therapeutic Targets;2023-11-02

3. Mechanism and application of feedback loops formed by mechanotransduction and histone modifications;Genes & Diseases;2023-08

4. Prognostic Value of EMT Gene Signature in Malignant Mesothelioma;International Journal of Molecular Sciences;2023-02-21

5. YB ‐1 regulates mesothelioma cell migration via snail but not EGFR , MMP1 , EPHA5 or PARK2;Molecular Oncology;2023-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP